Clinical Trials Browser

Withdrawn × Observational × Disease Progression × Clear all

NCT05116618 2022-09-21

Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged

Carcinoma, Non-Small-Cell Lung, Disease Progression